LFHC Technology and HPAPI Handling
LFHC technology allows a potent API to be wetted — dispersed or dissolved in a liquid or semi-solid vehicle — rather than processed as a dry powder. Wetting the API suppresses dust generation at the point of handling, reducing airborne particulate and operator exposure, and works alongside NextPharma Edinburgh’s dedicated high-containment suites for high-potent production. For low-dose and highly potent compounds, delivering the API as a homogeneous liquid dispersion also supports accurate dosing and content uniformity, avoiding the segregation risks of dry powder blends. The same wetting behaviour improves the dissolution of poorly water-soluble APIs.
Packaging
On-site packaging capabilities include two commercial-scale blister lines for automated blistering and cartoning, both with thermoform capability and full lid foil printing. Serialisation is available on site alongside the automated application of tamper-evident closures. Keeping filling, printing, packing and serialisation on one campus means a product does not leave the site between manufacture and finished-pack release. Further packaging capabilities, for example into bottles, are available within the NextPharma group network.
